Today, we have a bit more positive news with the announcement that Deep Longevity has added LifeHub and LifeClinic to its network of longevity-focused companies. This company plans to use multiple AI-based biological aging clocks to test a variety of longevity interventions, including supplements, drugs, and lifestyle choices.
Teaming up to offer longevity healthcare
This is good news because there is a serious lack of human data for longevity interventions, and this is a step in the right direction. Dr Alex Zhavoronkov, Chief Longevity Officer of Deep Longevity Inc. and his team have been developing AI-based biomarkers of aging for many years now. Their AI-based technology has been used successfully in the past for rapid drug discovery, and now they are going to be using it to search for promising longevity interventions.
LifeHub and LifeClinic are large wellness centers based in Hong Kong and are going to use the Deep Longevity aging biomarkers to support their healthcare and longevity services. Rather than waiting for symptoms to occur as current medicine typically does, the aging biomarkers that Deep Longevity uses will potentially allow them to spot signs of illness and longevity bottlenecks sooner. This could allow their personalized healthcare services to be more effective.
My dream is to build a longevity ecosystem, a seamless network, where life and health insurance companies are linked to healthcare providers, drug developers, and researchers using a range of standard aging biomarkers. The objectives of all participants of this ecosystem are aligned – they benefit from extending human longevity. Hong Kong is a great city to pilot this ecosystem. Many insurance companies have regional HQs there, there is a developed healthcare infrastructure, and it has the highest life expectancy on the planet – 85.2 years. We are very happy to partner with LifeHub and LifeClinic, as these organizations are consumerizing longevity and wellness and are developing a franchise approach similar to Starbucks for all kinds of IV drips. Coupled with a powerful set of aging clocks, this model may help demonstrate the effectiveness of some of the interventions and personalize them.
– Dr. Alex Zhavoronkov
The Press Release
Date, May 19th, 2021. Today, Deep Longevity (wholly owned by Regent Pacific Group Limited Hong Kong Stock Code: 00575) a leading provider of deep biomarkers of aging and longevity, LifeHub, and LifeClinic announced a collaboration to deploy an extensive range of AI-powered aging clocks to explore the effectiveness of longevity interventions including lifestyle choices and drug regimens.
Based in Hong Kong, LifeHub and LifeClinic are possibly the largest Functional Medicine-based Medical Wellness and Medical Clinic facilities in the region. They take a science-based approach to Health Optimization and Longevity by addressing their clients’ physiological imbalances that could stem from nutritional deficiencies or other factors like hormonal imbalances or the effects of environmental pollutants.
As part of the partnership, LifeHub and LifeClinic medical professionals are being engaged in advanced research with Deep Longevity and trained in deep aging clocks to provide their clients with biological age reports to customize their clients’ wellness journeys.
Deep Longevity aging clocks are supported by a number of academic publications that are summarized in a recent review titled “BioHorology and biomarkers of aging: Current state-of-the-art, challenges, and opportunities”.
Biological Aging clocks are a new holistic biomarker of health and wellbeing that reflect the biological age of the person, and not their passport age. These markers are usually much more predictive of mortality and can be used for early disease diagnosis, prevention, clinical trial management and in insurance applications. Deep Longevity is the original inventor of deep aging clocks – biomarkers of aging using deep learning and has granted patents on the technology.
“I am delighted that we will be able to use Deep Longevity’s most advanced aging clocks to assess and improve LifeHub and LifeClinic various youth extension products and services”, said Dr Jonathan Seah, Chairman of LifeHub and LifeClinic.
“The traditional approach to preventative medicine is focused on preventing disease by diagnosing the symptoms early or reducing the risks of disease. AI-guided longevity medicine goes much further than that by focusing on tracking the person’s rates of aging at many levels, on the identification of longevity bottlenecks, and on utilizing the latest advances in science and technology to slow down or potentially even reverse biological and psychological aging. We are very happy to have both LifeHub and LifeClinic join the rapidly growing network of our research and clinical partners focused on providing customers with extra years of productive and happy life”, said Dr Alex Zhavoronkov, Chief Longevity Officer of Deep Longevity Inc.
Original source here.